Japan's Medilabo triumphs in patent appeal as Indian court overturns controller's refusal
Japan's Medilabo RFP scored a win as an Indian court set aside a patent refusal, ruling the Controller of Patents erred by confusing a patentable drug composition with a non-patentable treatment...To view the full article, register now.
Already a subscriber? Click here to view full article